Sandimmun 50 mg/ml concentrate for solution for infusion

Spain
Brand name Sandimmun 50 mg/ml concentrate for solution for infusion
Form solution for infusion, concentrate
Active substance / Dosage
Prescription type Hospital Use Only
Registration number 56800
Sandimmun 50 mg/ml concentrate for solution for infusion solution for infusion, concentrate

Package Leaflet: Information for the User

Introduction

Package Leaflet: Information for the Patient

Sandimmun 50mg/ml concentrate for solution for infusion

ciclosporin

Read the entire leaflet carefully before you start taking this medicine, because it contains important information for you.

  • Keep this leaflet; you may need to read it again.

  • If you have any questions, ask your doctor or pharmacist.

  • This medicine has been prescribed for you only, and you should not give it to others, even if they have the same symptoms as you, because it may harm them.

  • If you experience any adverse reactions, consult your doctor or pharmacist, even if they are adverse reactions not listed in this leaflet. See section 4.

Leaflet Contents:

  1. What Sandimmun is and what it is used for
  2. What you need to know before using Sandimmun
  3. How to use Sandimmun
  4. Possible side effects
  5. How to store Sandimmun
  6. Contents of the pack and other information

1. What Sandimmun is and what it is used for

What Sandimmun is

The name of your medicine is Sandimmun. It contains the active substance ciclosporin. The concentrate is used to prepare a solution for intravenous infusion. It belongs to a group of medicines known as immunosuppressants. These medicines are used to reduce the body's immune responses.

What Sandimmun is used for and how it works

Sandimmun is used to suppress your body's immune system following an organ transplant, including bone marrow and stem cell transplants. It prevents rejection of transplanted organs by inhibiting the development of certain cells that would normally attack the transplanted tissue.

2. What you need to know before starting to use Sandimmun

Sandimmun will only be prescribed by a physician experienced in transplantation.

Carefully follow all instructions provided by your doctor. These may differ from the general information contained in this leaflet.

Do not use Sandimmun:

  • If you are allergic to cyclosporine or any of the other components of this medicine (listed in section 6; also see section “Sandimmun contains castor oil and ethanol”).

  • with medicines containing Hypericum perforatum (St. John's wort).

  • with medicines containing dabigatran etexilate (used to prevent blood clots after surgery) or bosentan and aliskiren (used to lower high blood pressure).

If any of these apply to you, do not use Sandimmun and inform your doctor. If you are unsure, consult your doctor before using Sandimmun.

Warnings and precautions

Before and during treatment with Sandimmun, inform your doctor immediately:

  • if you have any signs of infection, such as fever or sore throat. Sandimmun suppresses the immune system and may also affect your body’s ability to fight infections.
  • if you have liver problems.
  • if you have kidney problems. Your doctor will perform regular blood tests and may adjust your dose if necessary.
  • if you have high blood pressure. Your doctor will monitor your blood pressure regularly and may prescribe medication to lower it if needed.
  • if you have low levels of magnesium in your body. Your doctor may administer magnesium supplements, especially shortly after transplantation.
  • if you have high levels of potassium in your blood.
  • if you suffer from gout.
  • if you need to receive a vaccine.

If you experience any of the above conditions before or during treatment with Sandimmun, inform your doctor immediately.

Sun protection and sunlight exposure

Sandimmun suppresses your immune system. This may increase the risk of developing cancer, particularly of the skin and lymphatic system. Therefore, you should limit your exposure to sunlight and UV radiation by:

  • wearing appropriate protective clothing,
  • frequently applying a sunscreen with a high protection factor.

Talk to your doctor before taking Sandimmun:

  • if you have or have had alcohol-related problems,
  • if you have epilepsy,
  • if you have any liver problems,
  • if you are pregnant,
  • if you are breastfeeding,
  • if this medicine is prescribed for a child.

If any of these situations apply to you (or you are unsure), inform your doctor before taking Sandimmun. This is because this medicine contains alcohol (see section “Sandimmun contains castor oil and ethanol” below).

Monitoring during your treatment with Sandimmun

Your doctor will monitor:

  • cyclosporine blood levels, especially if you have undergone a transplant,
  • your blood pressure before starting treatment and regularly during treatment,
  • the function of your liver and kidneys,
  • your blood lipid levels (fats).

If you have any questions about how Sandimmun works or why it has been prescribed for you, consult your doctor.

Children and adolescents

Experience with Sandimmun in children is limited.

Elderly population (aged 65 years and older)

Experience with Sandimmun in elderly patients is limited. Your doctor should monitor your kidney function.

Other medicines and Sandimmun

Inform your doctor or pharmacist if you are taking, have recently taken, or might need to take any other medicines.

In particular, inform your doctor or pharmacist if you are taking any of the following medicines before or during treatment with Sandimmun:

  • Medicines that may affect your potassium levels. These include potassium-containing medicines, potassium supplements, potassium-sparing diuretics, and certain blood pressure-lowering medicines.

  • Methotrexate. Used to treat tumors, severe psoriasis, and severe rheumatoid arthritis.

  • Medicines that may increase or decrease cyclosporine (the active substance in Sandimmun) levels in your blood. Your doctor may check your cyclosporine blood level when starting or stopping treatment with other medicines.

  • Medicines that may increase cyclosporine levels in your blood include: antibiotics (such as erythromycin or azithromycin), antifungals (voriconazole, itraconazole), medicines used for heart disorders or high blood pressure (diltiazem, nicardipine, verapamil, amiodarone), metoclopramide (used to prevent vomiting), oral contraceptives, danazol (used to treat menstrual disorders), medicines used to treat gout (allopurinol), cholic acid and derivatives (used to treat gallstones), protease inhibitors used to treat HIV, imatinib (used to treat leukemia or tumors), colchicine, telaprevir (used to treat hepatitis C), cannabidiol (used, among other things, to treat epileptic seizures).

  • Medicines that may decrease cyclosporine levels in your blood include: barbiturates (used to help you sleep), certain anticonvulsants (such as carbamazepine or phenytoin), octreotide (used to treat acromegaly or neuroendocrine tumors in the intestine), antibacterial medicines used to treat tuberculosis, orlistat (used to help lose weight), herbal medicines containing St. John's wort, ticlopidine (used after stroke), certain blood pressure-lowering medicines (bosentan), and terbinafine (an antifungal medicine used to treat foot and nail infections).

  • Medicines that may affect your kidneys. These include: antibacterial medicines (gentamicin, tobramycin, ciprofloxacin), antifungal medicines containing amphotericin B, medicines used for urinary tract infections containing trimethoprim, cancer medicines containing melphalan, medicines used to reduce stomach acid (H2-receptor antagonists), tacrolimus, analgesics (non-steroidal anti-inflammatory drugs such as diclofenac), fibric acid derivatives (used to reduce blood fat levels).

  • Nifedipine. Used to treat high blood pressure and chest pain. If you are taking nifedipine during cyclosporine treatment, you may develop swollen gums that could grow over your teeth.

  • Digoxin (used to treat heart disorders), cholesterol-lowering medicines (HMG-CoA reductase inhibitors, also known as statins), prednisolone, etoposide (used to treat cancer), repaglinide (an oral antidiabetic medicine), immunosuppressants (everolimus, sirolimus), ambrisentan, and specific anticancer medicines called anthracyclines (such as doxorubicin).

  • Sodium mycophenolate or mycophenolate mofetil (an immunosuppressant), and eltrombopag (used to treat bleeding disorders).

If any of these situations apply to you (or you are unsure), inform your doctor or pharmacist before using Sandimmun.

Use of Sandimmun with food and drinks

Do not take Sandimmun with grapefruit or grapefruit juice. This is because it may affect how Sandimmun works.

Pregnancy and breastfeeding

Consult your doctor or pharmacist before using this medicine.

  • Inform your doctor if you are pregnant or planning to become pregnant. Experience with Sandimmun in pregnant women is limited. In general, Sandimmun should not be administered during pregnancy. If it is necessary for you to use this medicine, your doctor will discuss the potential benefits and risks of using it during pregnancy.
  • Inform your doctor if you are breastfeeding. Breastfeeding is not recommended during treatment with Sandimmun. This is because cyclosporine, the active substance, passes into breast milk and could affect your child.

Hepatitis C

Inform your doctor if you have hepatitis C. Your liver function may change with hepatitis C treatment, which could affect cyclosporine blood levels. Your doctor may need to closely monitor your cyclosporine blood levels and adjust the dose after starting hepatitis C treatment.

Driving and using machines

You may feel drowsy, disoriented, or experience blurred vision after taking Sandimmun. Exercise caution when driving or operating machinery while taking Sandimmun until you know how it affects you.

Sandimmun contains castor oil and ethanol

This medicine may cause severe allergic reactions because it contains castor oil.

Sandimmun concentrate for solution for infusion contains 278 mg of alcohol (ethanol) per ml, equivalent to 34.4% v/v. A dose of 100 mg of Sandimmun contains 556 mg of ethanol, which is approximately equivalent to 14 ml of beer or 6 ml of wine. The small amount of alcohol in this medicine will not have any noticeable effect.

3. How to use Sandimmun

Follow exactly the instructions given by your doctor for administering this medicine. If you are unsure, consult your doctor again.

What dose of Sandimmun you will receive

Your doctor will determine the correct dose of Sandimmun for you. This depends on your body weight and the reason for which this medicine is being administered.

  • The usual total daily dose is between 3 and 5 mg per kilogram of body weight. This is divided into two doses.
  • High doses are usually used before and immediately after your transplant. Lower doses are used once your transplanted organ or bone marrow has stabilized.
  • Your doctor will adjust the dose to one that is ideal for you. To do this, your doctor may need to perform some blood tests.

How Sandimmun will be used

The medicine will be diluted before use between 1:20 and 1:100 with either saline or 5% glucose solution, using an appropriate aseptic technique, and administered by slow intravenous infusion over 2 to 6 hours. Diluted solutions of the medicine must be discarded after 24 hours from preparation.

How long Sandimmun will be used

You will be switched to cyclosporine in capsule or oral solution form (both taken by mouth) as soon as possible.

If you have received more Sandimmun than you should

Excessive amounts of the medicine may affect your kidneys. Blood tests and regular hospital visits will be performed. This will give you the opportunity to discuss your treatment and any problems you may have with your doctor.

If you think you have received too much Sandimmun, inform your doctor immediately.

If you have any further questions about the use of this medicine, ask your doctor or pharmacist.

4. Possible adverse effects

Like all medicines, this medicine can cause adverse effects, although not everyone gets them.

Some adverse effects may be serious

Tell your doctor immediately if you notice any of the following serious adverse effects:

  • Signs of anaphylactoid reactions after intravenous administration of Sandimmun. These reactions may include redness of the face and upper chest, fluid in the lungs, difficulty breathing, wheezing, changes in blood pressure (you may feel faint), and rapid heart rate (tachycardia).
  • Like other medicines that affect the immune system, cyclosporine may affect your body's ability to fight certain infections and may cause tumors or other malignant diseases, especially of the skin. Signs of infection could include fever or sore throat.
  • Vision problems, lack of coordination, clumsiness, memory loss, difficulty speaking or understanding what others say, and muscle weakness. These could be signs of a brain infection called progressive multifocal leukoencephalopathy.
  • Brain problems with signs such as seizures, confusion, disorientation, reduced sensation, personality changes, agitation, insomnia, vision disturbances, blindness, coma, paralysis of part or all of the body, torticollis, lack of coordination with or without abnormal speech or eye movements.
  • Inflammation at the back of the eye, which may be associated with blurred vision. It may also affect your vision due to increased pressure inside the head (benign intracranial hypertension).
  • Liver injury and liver function abnormalities, with or without yellowing of the eyes or skin, nausea, vision loss, and dark urine.
  • Kidney problems, which may greatly reduce the amount of urine you produce.
  • Decrease in the number of red blood cells or platelets. These signs include pale skin, fatigue, shortness of breath, dark urine (a sign of red blood cell breakdown), unexplained bleeding or bruising, confusion, disorientation, inattention, and kidney problems.

Other adverse effects include:

Very common: may affect more than 1 in 10 people

  • Kidney problems.
  • High blood pressure.
  • Headache.
  • Uncontrollable body tremors.
  • Excessive growth of facial and body hair.
  • Increased blood lipids.

If any of these affect you severely, tell your doctor.

Common: may affect up to 1 in 10 people

  • Seizures.
  • Liver problems.
  • Increased blood sugar.
  • Fatigue.
  • Loss of appetite.
  • Nausea (feeling of sickness), vomiting, stomach discomfort/pain, diarrhea.
  • Excessive hair growth.
  • Acne, hot flushes.
  • Fever.
  • Decrease in the number of white blood cells.
  • Numbness or tingling sensation.
  • Muscle pain, muscle spasms.
  • Stomach ulcer.
  • Overgrowth of gum tissue, which may cover your teeth.
  • Increased levels of uric acid or potassium in the blood, decreased magnesium levels in the blood.

If any of these affect you severely, tell your doctor.

Uncommon: may affect up to 1 in 100 people

  • Symptoms of brain disturbances including sudden seizures, mental confusion, insomnia, disorientation, vision disturbances, unconsciousness, feeling of weakness in the limbs, impaired movement.
  • Skin rash.
  • Generalized swelling.
  • Weight gain.
  • Decrease in the number of red blood cells and platelets in the blood, which may increase the risk of bleeding.

If any of these affect you severely, tell your doctor.

Rare: may affect up to 1 in 1,000 people

  • Nerve disturbances causing numbness or tingling in the fingers and toes.
  • Pancreatitis (inflammation of the pancreas) with severe upper abdominal pain.
  • Muscle weakness, loss of muscle strength, leg or hand or generalized body muscle pain.
  • Destruction of red blood cells, including kidney problems with symptoms such as swelling of the face, abdomen, hands and/or feet, reduced urine output, difficulty breathing, chest pain, seizures, unconsciousness.
  • Changes in menstrual cycle, breast enlargement in men.

If any of these affect you severely, tell your doctor.

Very rare: may affect up to 1 in 10,000 people

  • Inflammation at the back of the eye, which may be associated with increased pressure inside the head and worsening of vision.

If this affects you severely, tell your doctor.

Frequency not known: Cannot be estimated from available data.

  • Severe liver problems with or without yellowing of the eyes or skin, nausea (feeling of sickness), loss of appetite, dark urine, swelling of the face, feet, hands, and/or entire body.
  • Bleeding under the skin or purple spots on the skin, sudden unexplained bleeding.
  • Migraine or severe headache, often with dizziness or associated symptoms (nausea, vomiting), and sensitivity to light.
  • Leg and foot pain.
  • Hearing impairment.

If any of these affect you severely, tell your doctor.

If you experience adverse effects, consult your doctor or pharmacist, even if they are adverse effects not listed in this leaflet.

Additional adverse effects in children and adolescents

No additional adverse effects are expected in children and adolescents compared to adults.

Reporting of adverse effects

If you experience any type of adverse effect, consult your doctor or pharmacist, even if they are possible adverse effects not listed in this leaflet. You may also report them directly via the Spanish Pharmacovigilance System for Human Medicines (www.notificaRAM.es). By reporting adverse effects, you can help provide more information on the safety of this medicine.

5. Storage of Sandimmun

  • Keep this medicine out of the sight and reach of children.
  • Do not use this medicine after the expiry date stated on the container.
  • This medicine does not require any special storage temperature.
  • After the ampoule has been opened, the contents should be diluted using appropriate aseptic technique and administered immediately by a healthcare professional. If not administered immediately, the diluted solution may be stored between 2°C and 8°C (in a refrigerator), provided that the total duration of storage and infusion is less than 24 hours. Any unused diluted solution should be discarded.

Medicines should not be disposed of via wastewater or household waste. Doing so helps protect the environment.

6. Contents of the pack and other information

Composition of Sandimmun

  • The active substance is cyclosporine. One ml of concentrate for solution for infusion contains 50 mg of cyclosporine. A 5 ml ampoule contains 250 mg of cyclosporine.
  • The other components are: anhydrous ethanol, polyoxyl 40 hydrogenated castor oil.

Appearance of Sandimmun and contents of the pack

Sandimmun concentrate for solution for infusion is supplied in ampoules containing 5 ml of concentrate. The concentrate is a yellowish-brown, transparent, oily liquid. It will be used by your doctor or nurse to prepare a solution which will be administered to you by slow intravenous infusion.

Pack containing 10 ampoules of 5 ml.

Only certain pack sizes may be marketed.

Marketing Authorisation Holder

Novartis Farmacéutica, S.A.

Gran Via de les Corts Catalanes, 764

08013 – Barcelona (Spain)

Telephone: +34 93 306 42 00

Manufacturer responsible for batch release

  • Novartis (Hellas) S.A.C.I.

12th km National Road Athens-Lamia

14451 Metamorphoses

Greece

  • Novartis Farma - Produtos Farmacêuticos S.A.

Avenida Professor Doutor Cavaco Silva, n.º 10E

Taguspark

2740-255 Porto Salvo

Portugal

  • Novartis Farma S.p.A.

Via Provinciale Schito 131

80058 Torre Annunziata, NA

Italy

  • Novartis Farmaceutica SA

  • Gran Via de les Corts Catalanes, 764

  • 08013 Barcelona
    Spain

  • Novartis Hungária Kft.

Bartók Béla út 43-47.

1114 Budapest

Hungary

  • Novartis Pharma B.V.

  • Haaksbergweg 16

  • 1101 BX Amsterdam
    Netherlands

  • Novartis Pharma GmbH

  • Jakov-Lind-Straße 5, Top 3.05

  • 1020 Wien
    Austria

  • Novartis Pharma S.A.S.

  • 8-10, rue Henri Sainte-Claire Deville,

  • 92500 Rueil-Malmaison,
    France

  • Novartis Sverige AB

  • Torshamnsgatan 48

  • 164 40 Kista
    Sweden

  • Novartis Farma S.P.A.

  • Viale Luigi Sturzo, 43

  • 20154-Milano (MI)
    Italy

  • Novartis Pharma GmbH

  • Sophie-Germain-Strasse 10

  • 90443 Nürnberg
    Germany

This medicinal product is authorised in the European Economic Area and the United Kingdom (Northern Ireland) under the following names:

Netherlands

Sandimmune

Austria, Belgium, Croatia, Czech Republic, Denmark, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Luxembourg, Norway, Poland, Portugal, Slovakia, Slovenia, Spain, Sweden, United Kingdom (Northern Ireland)

Sandimmun

Date of the most recent review of this leaflet: 03/2025

Other sources of information

Detailed information on this medicine is available on the website of the Spanish Agency for Medicines and Health Products (AEMPS) http://www.aemps.gob.es/